|
122 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
12 Trials |
|
2436 News |
|
| «12345678910111213...4950» |
- Trial primary completion date, Drug adherence, Adherence: RATA: Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders (clinicaltrials.gov) - Sep 28, 2016
P=N/A, N=330, Active, not recruiting, Sponsor: RAND
Trial primary completion date: Mar 2016 --> Dec 2016
- tenofovir disoproxil fumarate / Generic mfg.
Enrollment change: Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults (clinicaltrials.gov) - Sep 23, 2016
P2, N=63, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Mar 2016 --> Dec 2016 N=50 --> 63
- ||| Prezista (darunavir) / J&J
Trial initiation date: TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients (clinicaltrials.gov) - Sep 20, 2016
P2, N=330, Completed, Sponsor: Tibotec Pharmaceuticals, Ireland
N=50 --> 63 Initiation date: Dec 2004 --> Oct 2003
- |||| Prezista (darunavir) / J&J
Trial completion: TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients (clinicaltrials.gov) - Sep 19, 2016
P2, N=330, Completed, Sponsor: Tibotec Pharmaceuticals, Ireland
Initiation date: Dec 2004 --> Oct 2003 No longer recruiting --> Completed
- Trial initiation date: Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART (clinicaltrials.gov) - Sep 19, 2016
P0, N=105, Completed, Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group
No longer recruiting --> Completed Initiation date: Apr 2009 --> Aug 2009
- Isentress (raltegravir) / Merck (MSD)
Trial completion, Trial primary completion date, Adverse events: TaISENWITCH: Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study (clinicaltrials.gov) - Sep 15, 2016
P4, N=107, Completed, Sponsor: Lin, Hsi-Hsun, M.D.
Initiation date: Apr 2009 --> Aug 2009 Recruiting --> Completed | Trial primary completion date: Jun 2014 --> Feb 2015
- Enrollment closed: Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women. (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=702, Active, not recruiting, Sponsor: Harvard Medical School
Recruiting --> Completed | Trial primary completion date: Jun 2014 --> Feb 2015 Enrolling by invitation --> Active, not recruiting
- |||| fosamprenavir / Generic mfg.
Trial completion, Phase classification: Fosamprenavir Expanded Access (clinicaltrials.gov) - Sep 12, 2016
P4, N=85, Completed, Sponsor: ViiV Healthcare
Enrolling by invitation --> Active, not recruiting No Longer Available --> Completed | Phase classification: P3 --> P4
- Trial completion, Trial primary completion date: Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort (clinicaltrials.gov) - Sep 12, 2016
P=N/A, N=250, Completed, Sponsor: Boston Medical Center
No Longer Available --> Completed | Phase classification: P3 --> P4 Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Mar 2016
- |||| Selzentry (maraviroc) / ViiV Healthcare
Trial completion, Trial primary completion date: An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc (clinicaltrials.gov) - Sep 9, 2016
P4, N=120, Completed, Sponsor: ViiV Healthcare
Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Mar 2016 Active, not recruiting --> Completed | Trial primary completion date: Jan 2020 --> Aug 2016
- Trial primary completion date: Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002 (clinicaltrials.gov) - Sep 9, 2016
P2, N=93, Active, not recruiting, Sponsor: Barbara Ensoli, MD, PhD
Active, not recruiting --> Completed | Trial primary completion date: Jan 2020 --> Aug 2016 Trial primary completion date: Sep 2018 --> Jul 2016
- || Isentress (raltegravir) / Merck (MSD)
Trial primary completion date: RANIA: Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) (clinicaltrials.gov) - Sep 7, 2016
P2, N=100, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Trial primary completion date: Sep 2018 --> Jul 2016 Trial primary completion date: Aug 2016 --> Aug 2017
- Neupogen (filgrastim) / Kyowa Kirin, Amgen, plerixafor / Generic mfg.
Enrollment open: HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection (clinicaltrials.gov) - Sep 7, 2016
P1, N=13, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Trial primary completion date: Aug 2016 --> Aug 2017 Not yet recruiting --> Recruiting
- ||| lopinavir/ritonavir / Generic mfg.
Trial completion, Trial primary completion date, Adherence: Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program (clinicaltrials.gov) - Sep 2, 2016
P=N/A, N=173, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jun 2016
- Chantix (varenicline) / Pfizer
Trial completion, Observational data: LHIV: Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) (clinicaltrials.gov) - Sep 1, 2016
P=N/A, N=0, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jun 2016 Recruiting --> Completed
- Fuzeon (enfuvirtide) / Roche
Enrollment change, Trial withdrawal: ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression. (clinicaltrials.gov) - Aug 24, 2016
P4, N=0, Withdrawn, Sponsor: Hoffmann-La Roche
Recruiting --> Completed N=40 --> 0 | Terminated --> Withdrawn
- atorvastatin / Generic mfg.
Trial primary completion date: Modulation of Monocyte Activation by Atorvastatin in HIV Infection (clinicaltrials.gov) - Aug 22, 2016
P4, N=15, Active, not recruiting, Sponsor: University of Pennsylvania
N=40 --> 0 | Terminated --> Withdrawn Trial primary completion date: Dec 2015 --> Oct 2016
- | Adherence: Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX (clinicaltrials.gov) - Aug 19, 2016
P3, N=200, Recruiting, Sponsor: University of Pennsylvania
Trial primary completion date: Dec 2015 --> Oct 2016 Not yet recruiting --> Recruiting | Initiation date: Jul 2010 --> Jun 2011 | Trial primary completion date: Jun 2013 --> Jan 2017
- Trial completion, Combination therapy: Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) (clinicaltrials.gov) - Aug 19, 2016
P4, N=559, Completed, Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
Not yet recruiting --> Recruiting | Initiation date: Jul 2010 --> Jun 2011 | Trial primary completion date: Jun 2013 --> Jan 2017 Active, not recruiting --> Completed
- Rituxan (rituximab) / Roche
Trial completion, Enrollment change: High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk (clinicaltrials.gov) - Aug 19, 2016
P2, N=27, Completed, Sponsor: Azienda Ospedaliera Spedali Civili di Brescia
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=43 --> 27
- Enrollment change, Real-world evidence, Real-world: MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (clinicaltrials.gov) - Aug 16, 2016
P=N/A, N=907, Completed, Sponsor: University of Missouri-Columbia
Active, not recruiting --> Completed | N=43 --> 27 N=728 --> 907
- Enrollment change, Trial withdrawal: Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow (clinicaltrials.gov) - Aug 16, 2016
P=N/A, N=0, Withdrawn, Sponsor: University of Missouri-Columbia
N=728 --> 907 N=400 --> 0 | Completed --> Withdrawn
- Trial completion: IMEDI: HIV and Drug Use in Georgian Women (clinicaltrials.gov) - Aug 15, 2016
P=N/A, N=128, Completed, Sponsor: University of North Carolina, Chapel Hill
N=400 --> 0 | Completed --> Withdrawn Active, not recruiting --> Completed
- Trial primary completion date: Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women (clinicaltrials.gov) - Aug 9, 2016
P=N/A, N=500, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Jul 2017
- ribavirin / Generic mfg.
Trial completion: Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study (clinicaltrials.gov) - Aug 4, 2016
P4, N=10, Completed, Sponsor: Saint Michael's Medical Center
Trial primary completion date: Dec 2016 --> Jul 2017 Recruiting --> Completed
- Trial completion: Engaging Care for HIV-infected Adolescent Females. (clinicaltrials.gov) - Aug 3, 2016
P=N/A, N=178, Completed, Sponsor: Westat
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Neurobehavioral Model of HIV in Injection Drug Users (clinicaltrials.gov) - Aug 3, 2016
P1, N=836, Completed, Sponsor: The City College of New York
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Adherence: Medication Adherence in Human Immunodeficiency Virus (HIV) (clinicaltrials.gov) - Aug 2, 2016
P=N/A, N=33, Completed, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men (clinicaltrials.gov) - Aug 1, 2016
P2, N=20, Completed, Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | HSV vaccine (GEN-003) / Genocea, Shionogi
Trial completion: Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study (clinicaltrials.gov) - Jul 29, 2016
P2, N=37, Completed, Sponsor: Genocea Biosciences, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Isentress (raltegravir) / Merck (MSD)
Trial primary completion date: Transplantation and the Use of Raltegravir in HIV-Infected Patients (clinicaltrials.gov) - Jul 26, 2016
P=N/A, N=10, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Trial primary completion date: Oct 2015 --> Oct 2017
- efavirenz/emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence (clinicaltrials.gov) - Jul 23, 2016
P=N/A, N=28153, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Trial primary completion date: Oct 2015 --> Oct 2017 Recruiting --> Completed | N=22000 --> 28153 | Trial primary completion date: Mar 2016 --> Jun 2016
- Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=629, Active, not recruiting, Sponsor: Assistance Publique - H
Recruiting --> Completed | N=22000 --> 28153 | Trial primary completion date: Mar 2016 --> Jun 2016 Trial primary completion date: Mar 2016 --> Sep 2016
- Trial primary completion date: Empowerment Intervention for Young Women - Phase I (clinicaltrials.gov) - Jul 19, 2016
P1, N=17, Completed, Sponsor: Westat
Trial primary completion date: Mar 2016 --> Sep 2016 Trial primary completion date: Apr 2009 --> Jul 2009
- lopinavir/ritonavir / Generic mfg.
Trial primary completion date: Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=171, Active, not recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Trial primary completion date: Apr 2009 --> Jul 2009 Trial primary completion date: Nov 2015 --> Aug 2015
- lamivudine/stavudine/nevirapine / Hetero, Macleods, Cipla, Strides Pharma Science, Aurobindo, Emcure Pharma
Trial completion: Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa (clinicaltrials.gov) - Jul 18, 2016
P=N/A, N=54, Completed, Sponsor: University of Zimbabwe
Trial primary completion date: Nov 2015 --> Aug 2015 Active, not recruiting --> Completed
- Trial completion: BRM4: The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV (clinicaltrials.gov) - Jul 18, 2016
P=N/A, N=47, Completed, Sponsor: University of Miami
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| VCL-HB01 / Brickell
Trial completion: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults (clinicaltrials.gov) - Jul 16, 2016
P1/2, N=165, Completed, Sponsor: Vical
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Phase classification: PRO 140 by IV Administration in Adults With HIV-1 Infection (clinicaltrials.gov) - Jul 15, 2016
P2a, N=30, Completed, Sponsor: CytoDyn, Inc.
Active, not recruiting --> Completed Phase classification: P2 --> P2a
- Enrollment change, Trial primary completion date: TLCIDU Kenya: Testing and Linkage to Care for Injecting Drug Users in Kenya (clinicaltrials.gov) - Jul 13, 2016
P=N/A, N=10000, Recruiting, Sponsor: Yale University
Phase classification: P2 --> P2a N=4500 --> 10000 | Trial primary completion date: Apr 2016 --> Apr 2017
- Trial completion: HandiVIH: Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=1610, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
N=4500 --> 10000 | Trial primary completion date: Apr 2016 --> Apr 2017 Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: MICROGUT: Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=80, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Active, not recruiting --> Completed Recruiting --> Completed | N=100 --> 80 | Trial primary completion date: Dec 2015 --> Jun 2016
- Trial completion, Trial primary completion date: ANRS ECHAM;ECHAM: Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=460, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting --> Completed | N=100 --> 80 | Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Mar 2016
- Licensing / partnership, Enrollment change: Connect to Protect Partnerships for Youth Prevention Interventions: Phase II (clinicaltrials.gov) - Jul 12, 2016
P2, N=16706, Completed, Sponsor: Westat
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Mar 2016 N=1500 --> 16706
- |||| AGS-004 / CoImmune
Trial completion, Enrollment change, IO biomarker: Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption (clinicaltrials.gov) - Jul 12, 2016
P2b, N=53, Completed, Sponsor: Argos Therapeutics
N=1500 --> 16706 Active, not recruiting --> Completed | N=42 --> 53
- Enrollment open, Trial primary completion date: Viral and Host Factors in the Transmission and Pathogenesis of HIV (clinicaltrials.gov) - Jul 7, 2016
P=N/A, N=600, Recruiting, Sponsor: Rockefeller University
Active, not recruiting --> Completed | N=42 --> 53 Active, not recruiting --> Recruiting | Trial primary completion date: Jul 2016 --> Jul 2019
- Trial completion, Enrollment change: Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients (clinicaltrials.gov) - Jul 6, 2016
P=N/A, N=24, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Active, not recruiting --> Recruiting | Trial primary completion date: Jul 2016 --> Jul 2019 Recruiting --> Completed | N=30 --> 24
- Trial completion: Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART (clinicaltrials.gov) - Jul 5, 2016
P=N/A, N=214, Completed, Sponsor: Westat
Recruiting --> Completed | N=30 --> 24 Active, not recruiting --> Completed
- ||||||| Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) / Gilead
Trial completion: Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults (clinicaltrials.gov) - Jun 27, 2016
P3, N=158, Completed, Sponsor: Gilead Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: Test of an Intervention to Improve HIV Care (clinicaltrials.gov) - Jun 22, 2016
P=N/A, N=460, Completed, Sponsor: Baylor College of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Jun 2015